Elanco stock costs EUR 19.85 ahead of third-quarter results
Published on 10/08/2026 at 14:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Elanco stock was trading at EUR 19.85 at Lang and Schwarz on October 8, 2026 at 2:01 p.m. CEST, down 0.65 percent from the prior close of EUR 19.98. The company had reported second-quarter revenue of USD 1.368 billion on August 5, 2026, up 10 percent on a reported basis, while adjusted earnings per share reached USD 0.34, up 31 percent year over year, according to Benzinga.
Three milestones shape the picture
On August 5, 2026, Elanco reported second-quarter adjusted earnings per share of USD 0.34 against USD 0.27 consensus, a USD 0.07 comparison advantage, according to Benzinga. On August 6, 2026, UBS raised its price target from USD 31.00 to USD 33.00 and maintained a Buy rating, as reported by MarketScreener.
On September 15, 2026, Elanco said its first-half U.S. Pet Health revenue grew 9 percent organically in constant currency and international Pet Health revenue grew 9 percent on the same basis, according to MarketScreener.
What does the guidance mean?
Elanco raised its full-year 2026 outlook to USD 5.09 billion-5.14 billion of revenue, adjusted EBITDA of USD 1.01 billion-1.035 billion and adjusted earnings per share of USD 1.10-1.16, according to Benzinga. The revenue growth outlook moved to 6 percent-7 percent from 5 percent-7 percent, giving investors a measurable test for the second half.
Results date sets the next checkpoint
Elanco is scheduled to announce third-quarter 2026 results on November 6, 2026, with an earnings call at 8:00 a.m. EST, according to the company's investor relations page. The company had adjusted operating margin guidance upward by 75 basis points year over year for full-year 2026, including a 50 basis point gross margin benefit, according to Benzinga.
Elanco stock stays below its prior close
At Lang and Schwarz, Elanco stock was trading at EUR 19.85 on October 8, 2026 at 2:01 p.m. CEST, down 0.65 percent versus the prior close of EUR 19.98. The next course of trading is shown by the continuously updated real-time quote of Elanco stock.
Elanco stock facts
- Company: Elanco Animal Health Incorporated
- ISIN: US28414H1032
- Ticker: ELAN
- Primary exchange: NYSE
- Price Lang and Schwarz as of October 8, 2026, 2:01 p.m. CEST: EUR 19.85
- Change versus prior close: minus 0.65 percent
- Prior close Lang and Schwarz October 7, 2026: EUR 19.98
- Market capitalization: USD 11.2 billion as of October 7, 2026
- 52-week range: USD 19.40-27.98 as of October 7, 2026
- Sector / Industry: Health Care / Drug Manufacturers
- Next earnings date: November 6, 2026
Market context: Market report S&P 500.
